Onyx Biotec Limited IPO, GMP, Details, Price, And Review IPO Details
| Detail | Description |
|---|---|
| IPO Date | November 13, 2024 to November 18, 2024 |
| Listing Date | - |
| Face Value | ₹ 10 per share |
| Price Band | ₹ 58 to ₹ 61 per share |
| Lot Size | 2,000 Shares |
| Total Issue Size | 48,10,000 shares (aggregating up to ₹ 29.34 Cr) |
| Fresh Issue | 48,10,000 shares (aggregating up to ₹ 29.34 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Shareholding pre issue | 1,33,22,200 |
| Shareholding post issue | 1,81,32,200 |
| Market Maker portion | 2,44,000 shares |
About Onyx Biotec Limited IPO, GMP, Details, Price, And Review
Onyx Biotec Limited, established in May 2005, is a pharmaceutical company that specializes in the production of sterile water for injections. In addition to manufacturing sterile water, the company also offers contract manufacturing services for a variety of pharmaceutical products, including dry powder injections and dry syrups.
These products are distributed both in the Indian market and internationally. Onyx Biotec's clients include prominent pharmaceutical companies such as Hetero Healthcare, Mankind Pharma, Sun Pharmaceutical Industries, Aristo Pharmaceuticals, Macleods Pharmaceuticals, Mapra Laboratories, Axa Parenterals, FDC Limited, Zuventus Healthcare, Akums Drugs, and Reliance Life Sciences, among others.
Onyx Biotec IPO Overview:
• Issue Size: ₹29.34 crores (entirely fresh issue)
•Total Shares: 48.1 lakh equity shares
• Price Band: ₹58 to ₹61 per share
•Minimum Lot Size: 2,000 shares (can be applied for in multiples of 2,000)
•IPO Opening Date: November 13, 2024
•IPO Closing Date: November 18, 2024
•Lead Manager: Horizon Management Private Limited
•Registrar: Mas Services Limited
Onyx Biotec IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 49.89% of the Net Issue |
| Retail Shares Offered | Not less than 35.04% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15.07% of the Net Issue |
Objectives of Onyx Biotec IPO
- The Company proposes to utilize the Net Proceeds from the Issue towards the following objectives:
- Upgradation of existing manufacturing Unit I to manufacture large volume parenterals for intravenous use.
- Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections.
- Prepayment or repayment of all or a portion of certain loans availed by the Company.
- General Corporate Purposes.
Onyx Biotec Limited IPO, GMP, Details, Price, And Review Financial Information
Latest Revenue
1,054.11
₹ Crore
Profit After Tax
130.77
₹ Crore
Net Worth
2,618.64
₹ Crore
Total Borrowing
3,156.14
₹ Crore
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Total Borrowing | ||||
|---|---|---|---|---|---|---|---|---|---|
| 31 May 2024 | 7,476.57 | 1,054.11 | 130.77 | 2,618.64 | 3,156.14 | ||||
| 31 Mar 2024 | 7,413.58 | 5,387.43 | 303.16 | 2,487.87 | 3,078.04 | ||||
| 31 Mar 2023 | 5,872.36 | 3,961.65 | 184.46 | 1,820.16 | 2,922.83 | ||||
| 31 Mar 2022 | 3,683.84 | 4,498.09 | 335.29 | 1,637.59 | 1,224.39 | ||||
| Amount in ₹ Crore | |||||||||
IPO Estimated Listing Return
Based on the IPO Price of ₹61 (highest price band), the latest uploaded Grey Market Premium (GMP) of ₹58 and a lot size of 2000 shares.
Onyx Biotec Limited IPO, GMP, Details, Price, And Review GMP TREND (DAILY UPDATES)
| GMP Date | IPO Price | GMP | Last Updated |
|---|---|---|---|
| 2024-11-11 | ₹61 | ₹5 (8.20%) | 2024-11-11 |
Onyx Biotec Limited IPO, GMP, Details, Price, And Review Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 10.58% |
| ROCE | 12.19% |
| Debt/Equity | 1.24 |
| RoNW | 12.19% |
| Price/Earning P/E Ratio | N/A |
| PAT Margin (%) | 5.64% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 2.28 | 4.33 |
| P/E (x) | 26.81 | 14.1 |
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The India IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
Onyx Biotec Limited IPO, GMP, Details, Price, And Review IPO Timeline
| IPO Open Date | Wednesday, November 13, 2024 |
| IPO Close Date | Monday, November 18, 2024 |
| Basis of Allotment | Tuesday, November 19, 2024 |
| Initiation of Refunds | Wednesday, November 20, 2024 |
| Credit of Shares to Demat | Wednesday, November 20, 2024 |
| Listing Date | Thursday, November 21, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on November 18, 2024 |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| — | — | — |